193 related articles for article (PubMed ID: 24527399)
1. Temozolomide for treatment of brain metastases: A review of 21 clinical trials.
Zhu W; Zhou L; Qian JQ; Qiu TZ; Shu YQ; Liu P
World J Clin Oncol; 2014 Feb; 5(1):19-27. PubMed ID: 24527399
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide for the treatment of metastatic melanoma.
Quirbt I; Verma S; Petrella T; Bak K; Charette M;
Curr Oncol; 2007 Feb; 14(1):27-33. PubMed ID: 17576461
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.
Agarwala SS; Kirkwood JM; Gore M; Dreno B; Thatcher N; Czarnetski B; Atkins M; Buzaid A; Skarlos D; Rankin EM
J Clin Oncol; 2004 Jun; 22(11):2101-7. PubMed ID: 15169796
[TBL] [Abstract][Full Text] [Related]
4. The effect of temozolomide-based chemotherapy in patients with cerebral metastases from melanoma.
Bafaloukos D; Tsoutsos D; Fountzilas G; Linardou H; Christodoulou C; Kalofonos HP; Briassoulis E; Panagiotou P; Hatzichristou H; Gogas H
Melanoma Res; 2004 Aug; 14(4):289-94. PubMed ID: 15305160
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide for treating brain metastases.
Abrey LE; Christodoulou C
Semin Oncol; 2001 Aug; 28(4 Suppl 13):34-42. PubMed ID: 11550137
[TBL] [Abstract][Full Text] [Related]
6. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases.
Antonadou D; Paraskevaidis M; Sarris G; Coliarakis N; Economou I; Karageorgis P; Throuvalas N
J Clin Oncol; 2002 Sep; 20(17):3644-50. PubMed ID: 12202665
[TBL] [Abstract][Full Text] [Related]
7. Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer.
Ebert BL; Niemierko E; Shaffer K; Salgia R
Oncologist; 2003; 8(1):69-75. PubMed ID: 12604733
[TBL] [Abstract][Full Text] [Related]
8. Combining stereotactic radiosurgery and systemic therapy for brain metastases: a potential role for temozolomide.
Hardee ME; Formenti SC
Front Oncol; 2012; 2():99. PubMed ID: 22908046
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group.
Bafaloukos D; Gogas H; Georgoulias V; Briassoulis E; Fountzilas G; Samantas E; Kalofonos Ch; Skarlos D; Karabelis A; Kosmidis P
J Clin Oncol; 2002 Jan; 20(2):420-5. PubMed ID: 11786569
[TBL] [Abstract][Full Text] [Related]
10. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.
Brada M; Hoang-Xuan K; Rampling R; Dietrich PY; Dirix LY; Macdonald D; Heimans JJ; Zonnenberg BA; Bravo-Marques JM; Henriksson R; Stupp R; Yue N; Bruner J; Dugan M; Rao S; Zaknoen S
Ann Oncol; 2001 Feb; 12(2):259-66. PubMed ID: 11300335
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide in advanced malignant melanoma with small brain metastases: can we withhold cranial irradiation?
Boogerd W; de Gast GC; Dalesio O
Cancer; 2007 Jan; 109(2):306-12. PubMed ID: 17149755
[TBL] [Abstract][Full Text] [Related]
12. Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study.
Schadendorf D; Hauschild A; Ugurel S; Thoelke A; Egberts F; Kreissig M; Linse R; Trefzer U; Vogt T; Tilgen W; Mohr P; Garbe C
Ann Oncol; 2006 Oct; 17(10):1592-7. PubMed ID: 17005632
[TBL] [Abstract][Full Text] [Related]
13. How and when to use temozolomide to treat aggressive pituitary tumours.
Whitelaw BC
Endocr Relat Cancer; 2019 Aug; 26(9):R545-R552. PubMed ID: 31311005
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases.
Hofmann M; Kiecker F; Wurm R; Schlenger L; Budach V; Sterry W; Trefzer U
J Neurooncol; 2006 Jan; 76(1):59-64. PubMed ID: 16132502
[TBL] [Abstract][Full Text] [Related]
15. Combined modality treatment of glioblastoma multiforme: the role of temozolomide.
Nieder C; Adam M; Grosu AL
Rev Recent Clin Trials; 2006 Jan; 1(1):43-51. PubMed ID: 18393779
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide for the treatment of metastatic melanoma: a systematic review.
Quirt I; Verma S; Petrella T; Bak K; Charette M
Oncologist; 2007 Sep; 12(9):1114-23. PubMed ID: 17914081
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases.
Christodoulou C; Bafaloukos D; Kosmidis P; Samantas E; Bamias A; Papakostas P; Karabelis A; Bacoyiannis C; Skarlos DV;
Ann Oncol; 2001 Feb; 12(2):249-54. PubMed ID: 11300333
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
Tian J; Luo Y; Xiang J; Tang J
J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
[TBL] [Abstract][Full Text] [Related]
19. The treatment of brain metastases from malignant melanoma.
Douglas JG; Margolin K
Semin Oncol; 2002 Oct; 29(5):518-24. PubMed ID: 12407517
[TBL] [Abstract][Full Text] [Related]
20. Future directions for temozolomide therapy.
Yung WK
Semin Oncol; 2001 Aug; 28(4 Suppl 13):43-6. PubMed ID: 11550138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
